Catalyst Wire Dossier Catalyst Wire Dossier

Loteprednol Ophthalmic Suspension

loteprednol etabonate · Bausch & Lomb Incorporated
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Loteprednol Ophthalmic Suspension, covering 2012-03-21 to 2012-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge [Phase 2]

See pricing